Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

1st Source has been treading water for the past six months, recording a small return of 1.4% while holding steady at $60.48. Is now the time to buy SRCE? Or does the price properly account for its ...

SUWANEE, Ga.--(BUSINESS WIRE)--InVeris Training Solutions, the leading provider of integrated live-fire and virtual weapons training systems for military, law enforcement agencies and commercial ...

1st Source demonstrates steady growth, conservative underwriting, and efficient cost control, resulting in strong credit quality and attractive long-term performance. Current valuation is fair, with a ...

1st Source (SRCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

What is coronary heart disease? Coronary heart disease (CHD) is when your coronary arteries become narrowed by fatty material within their walls. These arteries supply your heart with blood containing ...

SRCE is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of SRCE shares has decreased $0.03 since the market last closed. This is a 0.05% ...

As of July 31, 2025, The Texas Heart Institute (THI) and The Texas Heart Institute Center for Cardiovascular Care (THICCC) will become part of The Texas Heart Institute at Baylor College of Medicine.